for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Medmen Enterprises Inc

MMEN.CD

Latest Trade

0.20CAD

Change

0.00(0.00%)

Volume

2,041,372

Today's Range

0.19

 - 

0.20

52 Week Range

0.19

 - 

1.83

As of on the Canadian National Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
0.20
Open
0.20
Volume
2,041,372
3M AVG Volume
15.16
Today's High
0.20
Today's Low
0.19
52 Week High
1.83
52 Week Low
0.19
Shares Out (MIL)
1,288.82
Market Cap (MIL)
252.28
Forward P/E
-2.23
Dividend (Yield %)
--

Next Event

Q2 2022 Medmen Enterprises Inc Earnings Release

Latest Developments

More

Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results

MedMen Enterprises Inc - Prevails In Lawsuit Against Former CFO James Parker

Medmen Reports 13% Year-Over-Year Quarterly Revenue Growth

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Medmen Enterprises Inc

MedMen Enterprises Inc. is a Canada-based cannabis retailer. The Company operates across the United States and stores in Los Angeles, Las Vegas and New York. It offers products under various categories, such as LuxLyte, MedMen, AlienLabs, Atlas, Bad Apple, Bloom, Breez, Caliva, BEBOE and Bic. It offers products under various categories, such as accessories, apparel, beverages, concentrates, edibles, flower, pets, pre rolls, topicals and vaporizers. It also offers products under various strain, such as Hybrid, Indica, Indica Dominant, Sativa and Sativa Dominant.

Industry

Retail (Specialty)

Contact Info

10115 Jefferson Blvd

CULVER CITY, CA

90232

United States

+1.424.3302082

https://medmen.com/

Executive Leadership

Michael Serruya

Chairman of the Board, Interim Chief Executive Officer

Reece Fulgham

Interim Chief Financial Officer

Tracy McCourt

President - Emerald Village West Hollywood, Chief Revenue Officer

Rozlyn Lipsey

Chief Operating Officer

David Hsu

Director

Key Stats

3.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2019

0.1K

2020

0.2K

2021

0.1K

2022(E)

0.2K
EPS (USD)

2019

-0.670

2020

-0.920

2021

-0.240

2022(E)

-0.075
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.35
Price To Book (MRQ)
0.86
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
135.13
LT Debt To Equity (MRQ)
90.99
Return on Investment (TTM)
-25.39
Return on Equity (TTM)
-31.79

Latest News

Latest News

Tilray buys convertible debt of pot producer MedMen, eyes U.S. market

Canadian pot producer Tilray Inc on Tuesday said it will buy convertible debt of struggling U.S. rival MedMen Enterprises Inc's for about $166 million in a deal with partners, giving it a pathway to enter the United States.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up